Point72 Hong Kong LTD Mei Pharma, Inc. Transaction History

Point72 Hong Kong LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.42 - $0.65 $162 - $251	387 New	387 $0
Q3 2021 Nov 15, 2021	SELL	$2.52 - $2.99 $1,506 - $1,788	-598 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.6 - $3.65 $1,554 - $2,182	598 New	598 $2,000
Q1 2021 May 17, 2021	SELL	$2.73 - $4.5 $1,801 - $2,970	-660 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$2.6 - $3.32 $1,716 - $2,191	660 New	660 $2,000

Q1 2020 May 15, 2020	SELL	$0.75 - $2.55 $2,334 - $7,938	-3,113 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$1.65 - $2.48 $5,136 - $7,720	3,113 New	3,113 $8,000

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $372M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.